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PCardiac Resynchronization Therapy
Optimizing Hemodynamics in
Heart Failure Patients by Systematic
Screening of Left Ventricular Pacing Sites
The Lateral Left Ventricular Wall and
the Coronary Sinus Are Rarely the Best Sites
Nicolas Derval, MD,* Paul Steendijk, PHD,† Lorne J. Gula, MD,‡ Antoine Deplagne, MD,*
Julien Laborderie, MD,* Frederic Sacher, MD,* Sebastien Knecht, MD,* Matthew Wright, PHD,*
Isabelle Nault, MD,* Sylvain Ploux, MD,* Philippe Ritter, MD,* Pierre Bordachar, MD,*
Stephane Lafitte, MD, PHD,* Patricia Réant, MD,* George J. Klein, MD,‡
Sanjiv M. Narayan, MD,§ Stephane Garrigue, MD,* Mélèze Hocini, MD,* Michel Haissaguerre, MD,*
Jacques Clementy, MD,* Pierre Jaïs, MD*
Pessac, France; Leiden, the Netherlands; London, Ontario, Canada; and San Diego, California
Objectives We sought to evaluate the impact of the left ventricular (LV) pacing site on hemodynamic response to cardiac
resynchronization therapy (CRT).
Background CRT reduces morbidity and mortality in heart failure patients. However, 20% to 40% of eligible patients may not
fully benefit from CRT device implantation. We hypothesized that selecting the optimal LV pacing site could be
critical in this issue.
Methods Thirty-five patients with nonischemic dilated cardiomyopathy referred for CRT device implantation were studied.
Intraventricular dyssynchrony and latest activated LV wall were defined by tissue Doppler imaging analysis be-
fore the study. Eleven predetermined LV pacing sites were systematically assessed in random order: basal and
mid-cavity (septal, anterior, lateral, inferior), apex, coronary sinus (CS), and the endocardial site facing the CS
pacing site. For each patient, dP/dTmax, dP/dTmin, pulse pressure, and end-systolic pressure during baseline
(AAI) and DDD LV pacing were compared. Two atrioventricular delays were tested.
Results Major interindividual and intraindividual variations of hemodynamic response depending on the LV pacing site
were observed. Compared with baseline, LV DDD pacing at the best LV position significantly improved dP/dTmax
(31  26%, p  0.001) and was superior to pacing the CS (15  23%, p  0.001), the lateral LV wall
(18  22%, p  0.001), or the latest activated LV wall (11  17%, p  0.001).
Conclusions The pacing site is a primary determinant of the hemodynamic response to LV pacing in patients with nonisch-
emic dilated cardiomyopathy. Pacing at the best LV site is associated acutely with fewer nonresponders and
twice the improvement in dP/dTmax observed with CS pacing. (J Am Coll Cardiol 2010;55:566–75) © 2010
by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.045(
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February 9, 2010:566–75 Effect of the Pacing Site in CRTatients that CRT improves quality of life, symptoms, and
xercise capacity and reduces all-cause as well as heart failure
orbidity and mortality (2–9). However, individual results
ary, and 20% to 40% of implanted patients do not respond to
RT according to these studies. Different strategies have been
eveloped to improve the responder rate to CRT such as
mproving pre-implantation patient selection and optimizing
evice programming and left ventricular (LV) lead position.
Based on previous studies, the current consensus is to
osition the LV lead in a lateral or posterolateral branch of
he coronary sinus (CS) (10,11). The concept that this site
s optimal for all patients has been challenged by hemody-
amic studies suggesting that the actual pacing site is of
ritical importance to CRT (12,13). However, such studies
See page 576
ave been limited by the number of LV pacing sites
ompared, either due to the constraints of CS anatomy or
he LV sites that are accessible by thoracotomy. To date, no
tudy has systematically investigated whether optimal LV
acing sites, selected individually from sites throughout the
V wall, might decrease the rate of nonresponders or
ptimize the benefit of CRT among responders.
We hypothesized that LV hemodynamics may be opti-
ized by pacing at sites that do not coincide with conven-
ional CS pacing sites and that the optimal site may lie
emote from the lateral LV wall or from sites of maximal
echanical LV delay. We tested this hypothesis by com-
aring the quantitative hemodynamic response to pacing at
ach of 10 transseptally accessed endocardial sites with the
esponse at the conventional CS site in patients with
onischemic cardiomyopathy and clinical indications for
RT.
ethods
atients. Thirty-five consecutive patients (mean age 63 
2 years; 28 men) with New York Heart Association
unctional class III or IV heart failure despite optimal
edical therapy, echocardiographic LV ejection fraction
35%, and a left bundle branch block pattern on the surface
lectrocardiogram with a QRS duration of 140 ms,
cheduled for implantation of a CRT device were included
n this single-center prospective study. The protocol was
pproved by the CHU Bordeaux ethics committee, and all
atients gave informed consent. All patients included in this
tudy had appropriate investigations to exclude reversible
auses of dilated cardiomyopathy and ischemic disease.
hey were on an optimal medical regimen, including
ngiotensin-converting enzyme inhibitors and beta-
lockers. Patients with ischemic or valvular cardiomyopathy
ere excluded from participation.
V pressure and volume measurements. To acquire real-
ime pressure-volume loops during the study, a 7-F com-
ined pressure-conductance catheter (CD Leycom, Zoeter- weer, the Netherlands) was
nserted through a femoral artery
nd advanced to the LV apex
hrough a 0.025-inch flexible
uidewire via the retroaortic
oute. The catheter was con-
ected to a cardiac function an-
lyzer (Leycom CFL512, CD
eycom) that recorded and dis-
layed online pressure and 7 seg-
ental volumes delineated by the
lectrodes at a sample frequency
f 250 Hz. For the purpose of
he present study, the volume
ata were not used.
The pigtail of the conductance
atheter was positioned in the apex and was adjusted to the
ong heart axis under fluoroscopic guidance. Temporary
acing leads were placed in the right atrium (Josephson,
ard Electrophysiology, Lowell, Massachusetts) and in a
ateral branch of the coronary sinus (Xtrem catheter, ELA
edical, Le Plessis-Robinson, France) via the femoral vein.
deflectable-tip catheter (Celsius 4 mm, Biosense Webster
nc., Diamond Bar, California) was placed in the left
entricle via the transseptal route and used for pacing the
redetermined LV endocardial sites. Pulsatile arterial pres-
ure was measured continuously.
chocardiographic assessment. In addition to the invasive
emodynamic study described in detail in the following,
atients underwent echocardiography with intraventricular
yssynchrony assessment. Recordings were performed using
GE Vingmed Ultrasound system (System 7, GE Vingmed
ltrasound AS, Horten, Norway) equipped with a 2.5- to
-MHz imaging probe and offline cine loop analysis soft-
are. All images were recorded digitally and analyzed by the
ame operator. Mitral regurgitation was quantified and
raded by the proximal isovelocity surface area method.
ntra-LV dyssynchrony was determined using tissue Dopp-
er imaging (TDI) to assess segmental wall motion, as
reviously described (14–16). In brief, TDI was performed
y placing the sample volume in the middle of the basal and
id-segmental portion of the septal, lateral, inferior, ante-
ior, posterior, and anteroseptal walls. Gain and filter
ettings were adjusted as needed to eliminate background
oises and to allow a clear tissue signal. The TDI velocities
ere recorded and measured at a sweep speed of 100 mm/s
sing online calipers. The intra-LV delaypeak was then
alculated as the difference between the shortest and longest
f the 12 segmental electromechanical delaypeak values, and
he latest activated LV wall was defined as the wall with the
ongest electromechanical delaypeak (14–17).
xperimental protocol. All measurements during baseline
nd LV pacing were performed at a constant atrial pacing
ate of 10 beats on the resting heart rate (Table 1). Two
trioventricular delays (AVDs) were tested; a short AVD
Abbreviations
and Acronyms
AVD  atrioventricular
delay
BiV  biventricular
CRT  cardiac
resynchronization therapy
CS  coronary sinus
ESP  end-systolic
pressure
LV  left ventricular
PP  pulse pressure
TDI  tissue Doppler
imagingas set as the longest AVD that allowed complete ventric-
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Effect of the Pacing Site in CRT February 9, 2010:566–75lar capture, whereas the long AVD was 50 ms longer.
leven predetermined LV pacing sites were assessed in a
andomized order during the protocol: 9 endocardial LV
ites basal and mid-cavity (septal, anterior, lateral, inferior);
pex; CS; and 1 endocardial site facing the CS pacing site
Fig. 1).
atient Characteristics (n  35)Table 1 Patient Characteristics (n  35)
Age (yrs) 63 12
Sex (male/female) 28/7
NYHA functional class (III/IV) 35/0
LBBB (%) 100
AVD (ms)
Long 136 16
Short 84 15
QRS duration
Baseline 165 28
SAVD 210 34*
LAVD 194 34*
Heart rate (beats/min)
Baseline 72 12
Paced 86 14
LVEF (%) 28 7
LVEDD (mm) 71 10
MR (grade III/IV) 4/0
Left ventricular dyssynchrony (ms) 81 20
p  0.001.
AVD  atrioventricular delay; LAVD  long atrioventricular delay; LBBB  left bundle branch
lock; LVEDD  left ventricular end-diastolic diameter; LVEF  left ventricular ejection fraction;
R  mitral regurgitation; NYHA  New York Heart Association; SAVD  short atrioventricular
elay.
Figure 1 Distribution of LV Pacing Sites and Catheter Position
(A) Predetermined left ventricular (LV) pacing site used during the study. The LV c
tal aspects), and 1 apex. One site was epicardial in a lateral branch of the corona
position during the study.For each pacing site, 3 pacing modes were successively
pplied: AAI, then DDD (i.e., not BiV) with long and short
VDs. Hemodynamic data were acquired consecutively 60 s
fter any change in the pacing mode or site, and periods of at
east 20 s of steady state were selected for offline analysis. A
2-lead electrocardiography at 100 mm/s was performed, and
rterial pressure measurements were collected at each pacing
ite and mode.
emodynamic data analysis. Analysis of the pressure-
olume loops was performed with custom software (Circlab,
eiden University Medical Center, Leiden, the Nether-
ands) as described previously (18). For each patient, pacing
ode, and site, hemodynamic indexes were calculated as the
ean of all beats during a 20-s steady-state period. LV
unction was quantified by maximal and minimal rates of
V pressure change (dP/dTmax, dP/dTmin), end-
ystolic pressure (ESP), and arterial pulse pressure (PP).
Hemodynamic results at each pacing site and mode were
xpressed as a percentage of variation from the control that
as defined as data from AAI pacing. Notably, these AAI
acing data were remeasured immediately before each ven-
ricular pacing site was tested to account for hemodynamic
lterations over time. We arbitrarily defined the best and
orst sites as the best and worst improvement of the
onsidered hemodynamic parameter by LV DDD pacing
ompared with baseline (AAI pacing) among the 11 tested
ites.
omparison of lead placement strategies. Four different
trategies to select the optimal LV pacing site were
as divided into 9 zones: 4 basal, 4 mid-cavity (inferior, lateral, anterior, and sep-
s (CS), and 1 site was endocardial just facing the CS pacing site. (B) Catheteravity w
ry sinu
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February 9, 2010:566–75 Effect of the Pacing Site in CRTompared: 1) individually based strategy in which the LV
acing site was defined for each patient as the site
ssociated with the greatest improvement of dP/dTmax;
) conventional strategy in which the LV pacing site was
efined as the CS pacing site using traditional clinical
riteria; 3) echo-guided strategy in which the LV pacing
ite was defined as the latest mechanically activated LV
all; and 4) lateral area strategy in which the endocardial
V pacing site was defined as the lateral LV wall, with
he basal and mid-lateral sites being pooled and consid-
red as a single site.
andomization and statistical analysis. Each patient was
andomized independently according to an 11  11 Latin
quare (11 different sequences of 11 pacing sites). Briefly,
he Latin square was generated by random permutations
f a basic sequence of 11 pacing sites. Each sequence was
pplied to 3 patients. Statistical analysis was performed
sing SAS software version 9.1 (SAS Institute, Cary,
orth Carolina). Values of p  0.05 were considered
ignificant. All results are expressed as mean  SD.
arametric tests were used as appropriate for normally
istributed data. Paired t tests were performed to com-
are values obtained for individual subjects at paired
acing locations and to compare values at single sites
hile pacing with a long versus short AVD. Comparison
f multiple pacing sites was performed using simple
-way analysis of variance testing.
esults
atients. Between 2004 and 2008, 35 eligible consecutive
atients were enrolled in the study (28 men, mean age 63
2 years); their baseline characteristics are summarized in
able 1. Two patients were excluded from final analysis due
o the pressure-volume loop computer failure before the
Figure 2 Patient #20: Best and Worst Sites
Patient #20: dP/dT recorded at the worst and best left ventricular pacing sitemaxeginning of the procedure. All patients had nonischemic
ilated cardiomyopathy with severely depressed LV func-
ion (mean LV ejection fraction 28  7%). Mean LV
nd-diastolic diameter was 71  10 mm. Severe mechanical
ntra-LV dyssynchrony was present at baseline (mean max-
mal delay 81  20 ms). Of 27 patients with usable TDI
ata, the most delayed site was the lateral wall in 48% (n 
3), the inferior wall in 22% (n  6), the inferolateral wall
n 22% (n  6), and the inferoseptal wall in 7% (n  2) of
atients. The CS catheter was positioned at the mid-lateral
V wall in 77% of the patients, at the mid-anterolateral LV
all in 17% of the patients, and at the mid-posterolateral
V wall in 6% of the patients.
eneral results in the population. In total, 1,155 pacing
onditions were tested in the entire study; of these, 1,034
90%) were usable.
NTRAINDIVIDUAL VARIATIONS. Within individual pa-
ients, substantial variations of hemodynamic response de-
ending on the LV pacing site were found. An example is
hown in Figure 2 (Patient #20): dP/dTmax (compared
ith baseline), during pacing at the mid-lateral site, was
ssociated with a 93% improvement, whereas pacing at
he basal anterior site was associated with a 19% increase
long AVD).
NTERINDIVIDUAL VARIATIONS. The hemodynamic re-
ponse to LV pacing varied significantly among individuals
n the study. When all the tested LV pacing sites are taken
nto consideration, the maximal range of hemodynamic
esponse between patients was dP/dTmax from 31% to
93% and 32% to 81%; dP/dTmin from 29% to
67% and 32% to 68%; PP from 51% to 133% and
61% to 140%; ESP from 23% to 48% and 40% to
42%, for long and short AVDs, respectively.
pacing and DDD pacing mode, long atrioventricular delay.s. AAI
b
v
a
C
l
d
w
s
d
(
v
f
I
C
o
h
t
a
S
p
r
p
c
570 Derval et al. JACC Vol. 55, No. 6, 2010
Effect of the Pacing Site in CRT February 9, 2010:566–75The mean improvements in dP/dTmax by pacing at the
est compared with the worst LV sites were 31  26%
ersus 2  12% and 26  23% versus 1  13% for long
nd short AVDs, respectively (Fig. 3).
OMPARISON OF LONG AND SHORT AVDS. Pacing with a
ong AVD was associated with a significantly shorter QRS
uration than pacing with a short AVD (p 0.001). Pacing
ith a long versus a short AVD was associated with
ignificantly greater hemodynamic improvement in dP/
Tmax (31  26% vs. 26  23% [p  0.005]); dP/dTmin
19  17% vs. 17  16% [p  0.002]), and ESP (14  11%
s. 12 10% [p 0.03]). No significant change was observed
or PP (36  30% vs. 32  28% [p  0.09]) (Fig. 4).
Figure 3 Best and Worst Sites for Each Individual (dP/dTmax
Percentage of change in dP/dTmax for each individual patient at best (open bars
Figure 4 Comparison of Hemodynamic
Change for Both AV Delays at Best Location
AV  atrioventricular; ESP  end-systolic pressure; LAV  long
atrioventricular delay; PP  pulse pressure; SAV  short atrioventricular delay.mpact of LV pacing site on hemodynamic response.
omparison of the 11 pacing sites demonstrated that none
f the tested sites was consistently associated with the best
emodynamic improvement (Fig. 5). The distribution of
he best pacing site for each individual was uniformly spread
mong the 11 tested sites (dP/dTmax, long AVD) (Fig. 6).
imilar results were found with the other hemodynamic
arameters (data not shown).
For individual patients, pacing at the best location
esulted in a significant improvement of all hemodynamic
arameters (dP/dTmax, dP/dTmin, PP, and ESP)
ompared with CS pacing, whereas pacing at the worst
orst (solid bars) left ventricular pacing location (long atrioventricular delay).
Figure 5 Site by Site, Mean Percentage
of Change in dP/dTmax
Mean percentage of change in dP/dTmax for each pacing site compared with
best and worst left ventricular pacing sites, long atrioventricular delay. ant 
anterior; CS  coronary sinus; endo  endocardial; inf  inferior; lat  lateral;
sept  septal.)
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February 9, 2010:566–75 Effect of the Pacing Site in CRTite altered all hemodynamic parameters compared with
S pacing (Fig. 7, Table 2). When the LV pacing site
as chosen according to the best improvement of dP/
Tmax, pacing at this site was associated with a significant
mprovement of the other hemodynamic parameters (Fig. 8,
able 2).
OMPARISON OF ENDOCARDIAL AND EPICARDIAL PACING.
acing at an endocardial site just facing the epicardial CS
acing site was not associated with a significantly greater
mprovement of dP/dTmax, PP, or ESP with both AVDs.
owever, –dP/dTmin increased from 0.4  13% to 8.5 
6% with long AVDs (p 0.001) and from0.9 14% to
.8  18% with short AVDs (p  0.01) when pacing the
S and the equivalent endocardial site, respectively.
Figure 6 Distribution of Best and Worst Sites
Distribution of best (A) and worst (B) left ventricular pacing site among the 11 tes
Figure 7 Average Hemodynamic Change at Best Site,
Worst Site, and CS Site, Long AVD
Comparison of the magnitude of change of dP/dtmax, dP/dtmin, pulse pres-
sure, and end-systolic pressure (ESP) at best site, worst site, and coronary
sinus (CS) site, long atrioventricular delay (AVD). *p  0.01.omparison of lead placement strategies
. Pacing at the best site (individually-based approach) was
associated with a mean improvement of dP/dTmax of
31  26%. LV pacing at the best position was
associated with 20% improvement in 19 patients
(54%), between 10% and 20% improvement in 9
patients (26%), between 0% and 10% improvement in
2 patients (6%), and 0% in 3 patients (9%) (long
AVD, dP/dTmax).
. Pacing from within the CS (conventional strategy) was
associated with a mean improvement of dP/dTmax of
15  23% (p  0.001 vs. best site) (Table 3). It was
associated with the best improvement of dP/dTmax
(long AVD) in only 3 patients (9%) and was the worst
position in 6 patients (17%). LV pacing from the CS
was associated with 20% improvement in 10 patients
(29%), between 10% and 20% improvement in 4
patients (11%), between 0% and 10% improvement in
9 patients (26%), and 0% in 8 patients (23%)
(dP/dTmax, long AVD).
. Pacing the lateral LV wall (lateral area strategy) was
associated with a mean improvement of 18  22% (p 
0.001 vs. best site). The lateral area was the best site in
8 patients (23%) and at the worst position in 9 patients
(26%). LV pacing at the lateral area was associated with
20% improvement in 13 patients (37%), between 10%
and 20% improvement in 5 patients (14%), between 0%
and 10% improvement in 11 patients (31%), and0% in
4 patients (11%) (dP/dTmax, long AVD).
. Pacing the latest activated LV wall (echo-guided strat-
egy) was associated with a mean improvement of 11 
17% (p 0.001 vs. best site). The latest site was the best
site fordP/dTmax in 2 patients (6%) and at the worst in
tes.ted si3 patients (9%). LV pacing at the latest site was associ-
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between 10% and 20% improvement in 4 patients (11%),
between 0% and 10% improvement in 9 patients (26%),
and 0% in 6 patients (17%) (dP/dTmax, long AVD).
Comparison of the 3 current strategies (conventional CS
acing, lateral area, and echo guided) demonstrated no
ignificant change in acute dP/dTmax (p  0.05). LV
acing using an individually based approach was associated
ith a delta (absolute value) of hemodynamic improvement
f 16% compared with conventional CS pacing, 13% com-
ared with LV pacing at the lateral area, and 20% compared
ith LV pacing at the latest wall (echo-guided).
iscussion
he present study demonstrates that acutely: 1) the LV
acing site is a major determinant of the hemodynamic
esponse; 2) major interindividual and intraindividual vari-
tions in response to LV pacing are observed; 3) an optimal
V pacing site cannot be defined a priori and is specific to
ach individual; 4) an individually-based approach to pacing
t the best possible location is superior to the other pacing
trategies: pacing from within the CS, at the lateral, or at
Figure 8 Impact of Left Ventricular
Pacing at the Best dP/dTmax Location
Comparison of hemodynamic change when the pacing site is defined by the
site associated with the greatest improvement of dP/dTmax. AV  atrioven-
tricular; CS  coronary sinus; ESP  end-systolic pressure; PP  pulse
pressure.
omparison of Lead Placement StrategiesTable 3 Comparison of Lead Placement Strategies
Left Ventricular Lead Strategy
% Change of
dP/dTmax Long AVD p Value
Individually based (best site) 31 26
Conventional (CS pacing) 15 23 0.001
Lateral wall 18 22 0.001
Echo-guided latest wall 11 17 0.001H
e
an
d T V   P E
C
S
 p value for each strategy versus individually-based strategy.
Abbreviations as in Tables 1 and 2.
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February 9, 2010:566–75 Effect of the Pacing Site in CRThe most delayed wall; 5) endocardial pacing may improve
he diastolic function compared with epicardial pacing; and
) in LV pacing, a long AVD is consistently superior to a
hort AVD.
ole of the LV pacing site. This study demonstrates the
mportance of the LV pacing site as a primary determinant
f the short-term hemodynamic response. There were
ignificant variations in the hemodynamic response to LV
acing among patients and within each individual. In some
atients, there was as much as an 81% difference in
dP/dTmax change between the best and worst locations.
mportantly, we observed that the best site is not a prede-
ermined area of the LV but is specific to each patient.
hese results are consistent with those of a previous study
y Dekker et al. (12), who found that the hemodynamic
esponse to biventricular (BiV) pacing varies widely with the
V sites. In 11 patients with heart failure eligible for CRT,
hey showed that pacing at the optimal epicardial LV site
cutely increased LV stroke volume, dP/dTmax, and ejec-
ion fraction compared with baseline, whereas suboptimal
ites did not change or worsened LV function. In their
tudy, patients included were those in whom conventional
RT had failed and were mainly patients with ischemic
ardiomyopathy. Importantly, only the LV sites that were
ccessible by mini-invasive surgery were tested in that study.
ur study confirms those results in a larger group of
onischemic patients with unrestricted access to LV sites
hat were systematically assessed in a random order.
The limited number of pacing sites that are accessible via
he CS were associated with important hemodynamic con-
equences in our study: 1) pacing at the best LV site was
ssociated with twice the increase of dP/dTmax compared
ith CS pacing; 2) pacing the CS was the best location in
nly 3 patients (9%); and 3) in 8 patients (23%), CS pacing
ad either no effect or a detrimental effect on dP/dTmax
nonresponders), whereas this was observed in only 3 patients
9%) with LV pacing when all sites were tested (true
onresponders). These data suggest that some of the clinical
onresponders with CS pacing would benefit from LV
acing using an individually-based approach.
trategy to define the LV pacing site. To date, there is no
lear consensus as to the optimal strategy regarding LV lead
lacement. Current practice for CRT is to place the LV lead
t the lateral wall by either a percutaneous (CS) or surgical
pproach. This is based on a previous study suggesting that
ositioning the LV pacing lead at the lateral wall resulted in
greater improvement of dP/dTmax compared with the
nterior wall (10); however, in that study, only 2 LV sites
ere assessed. The present study demonstrates that only a
inority of patients had the best site along the lateral LV
all. The classic basal lateral site was the best site in terms
f dP/dTmax in only 9% of patients and the mid-lateral
ite in 14% (long AVD), with similar results in all other
easured hemodynamic parameters.
It has been shown that echocardiography reproduciblydentifies the latest LV wall to be activated and accurately tuantifies the intraventricular delay. Ansalone et al. (11)
tudied 31 patients eligible for CRT and showed that the
reatest improvement of LV performance was found in
atients paced at the most delayed site. Recently published
ata demonstrated that pacing the site of latest mechanical
ctivation was associated with a better long-term prognosis
nd reverse LV remodeling after 6 months of CRT (19).
owever, only 3 different LV pacing sites accessible via the
S were tested (all basal sites, lateral [45%], posterior
49%], and anterior [5%]). In our study, there were no
ifferences among CS pacing, lateral wall pacing, and
cho-guided strategy. In contrast, the individually-based
pproach significantly improved hemodynamic parameters.
he large number of sites systematically tested in the
resent protocol in all patients may explain why our results
re in disagreement with those of previous studies.
The reason that such important variations of hemody-
amic response between LV sites are observed is unclear.
he selected population was comparable to previous trials of
RT in terms of QRS duration (165  28 ms), LV
unction (ejection fraction 28  7%), and mitral regurgita-
ion (4 patients with grade III) (3,4,6,7). In the present
tudy, only patients with nonischemic cardiomyopathy were
elected, and large areas of ischemic necrosis or scar cannot
xplain those variations. However, it has been demonstrated
hat severe nonischemic cardiomyopathy with left bundle
ranch block is a complex electrical disease resulting from
onduction delay located at several anatomic levels (20–22).
uricchio et al. (23) performed endocardial 3-dimensional
apping on 24 patients with nonischemic cardiomyopathy
nd described the presence of a transmural functional line of
lock resulting in atypical LV activation sequence around
hese lines (U-shaped pattern). It may be that the presence
f a line of electrical block in the left ventricle may
ontribute to regional, and hence interindividual, variation
n hemodynamic response to the LV pacing site.
linical implications: which parameter to choose? The
efinition of the best or worst site for an individual patient
ay vary according to the parameter considered. Discordant
esponses at a single LV pacing site were sometimes
bserved, but no studies have demonstrated the superiority
f a single parameter to predict long-term clinical response.
elson et al. (24) showed that LV dP/dTmax is a more
ensitive parameter than LV and aortic PP in the evaluation
f CRT effects. In our study, the best site was selected on
V dP/dTmax and was associated with a significant
mprovement of all the other measured parameters for both
VDs. In addition, LV dP/dTmax has been the most
xtensively used parameter and is relatively easy to obtain.
ndocardial versus epicardial pacing. In this study, we
ested endocardial and epicardial pacing at the exact same
ocation to investigate whether endocardial pacing was
etter, as has been suggested by a previous study (25). The
esults on dP/dTmax, PP, and ESP were not significantly
ifferent, but endocardial pacing was significantly superior
o epicardial pacing on dP/dTmin at both AVDs. In 2001,
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Effect of the Pacing Site in CRT February 9, 2010:566–75arrigue et al. (25) compared 15 patients who underwent
mplantation of a conventional BiV pacing (epicardial pac-
ng) device with 8 patients with a BiV implantable
ardioverter-defibrillator where the LV lead was inserted
ndocardially in the LV cavity via the transseptal route.
hey showed that endocardial BiV pacing was associated
ith better LV filling and systolic performance. The reason
hat dP/dTmin is notably improved by endocardial pacing
s not clear. The impact of CRT on diastolic dysfunction is
till a matter of debate, and further studies are needed to
onfirm our results (12,26,27).
mpact of AVD. Two different AVDs were tested in our
tudy. By allowing some degree of fusion between intrinsic
V activation by the right bundle and LV pacing, the long
VD was associated with a shorter QRS complex compared
ith a short AVD. In all but 1 parameter, pacing with a
ong AVD had a greater impact on hemodynamic improve-
ent. van Gelder et al. (28) reported similar results. They
howed that LV pacing with optimal AVD allowing fusion
ith intrinsic activation was associated with higher LV
dP/dTmax than BiV pacing.
tudy limitations. The main limitation of this study is the
elative complexity of the protocol. Data acquisition and
nalysis are lengthy and would be difficult to use routinely to
efine the best site before implantation. However, we
emonstrated that selecting the optimal site has an impor-
ant role in the response to LV pacing. This should promote
tudies of alternative approaches to the conventional CRT
sing the CS.
A second limitation of this study is that to keep the
acing protocol relatively simple, DDD LV pacing was
hosen instead of BiV pacing. However, several previous
tudies demonstrated the noninferiority of LV pacing
ompared with BiV pacing (28 –31), but further studies
f BiV pacing are needed to confirm our results. We
cknowledge that VDD pacing would have been closer to
he usual resynchronization pacing strategy, but DDD
V pacing was the only option to ensure a steady rate for
ccurate hemodynamics throughout the study and there-
ore a fair comparison of the pacing sites and modalities.
It is unlikely that our results were limited by the use of
ndocardial pacing because the results did not significantly
iffer for pacing at endocardial and epicardial (CS) sites.
oreover, some of these sites were located away from the
ateral wall, lessening concerns that differences between
ndocardial and epicardial pacing sites may be regional.
This study was also limited to short-term hemodynamic
hanges, and their relationship to clinical improvement was
ot evaluated. However, Steendijk et al. (32) studied 22
atients implanted with a CRT device based on conven-
ional criteria. They showed that short-term improvement
f invasive hemodynamic parameters (including dP/dTmax,
dP/dTmin, and ESP) was maintained at 6-monthollow-up after CRT device implantation.onclusions
his hemodynamic study shows that the LV pacing site is a
rimary determinant of the response to LV pacing in
atients with nonischemic dilated cardiomyopathy. Pacing
t the best LV site is associated acutely with fewer nonre-
ponders and twice the improvement in dP/dTmax observed
ith CS pacing. These results suggest that new approaches
llowing unrestricted access to LV pacing sites need to be
ssessed because conventional pacing from the CS is rarely
ptimal.
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